Sumitomo Pharma Co., Ltd.
SMDPY · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $23,635 | -$314,929 | -$96,714 | $40,600 |
| Dep. & Amort. | $25,562 | $37,765 | $41,263 | $38,348 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$18,770 | -$95,847 | $34,878 | -$33,733 |
| Other Non-Cash | -$13,927 | $131,118 | $32,510 | -$13,976 |
| Operating Cash Flow | $16,500 | -$241,893 | $11,937 | $31,239 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$8,498 | -$15,730 | -$12,742 | -$13,494 |
| Net Acquisitions | $1,458 | $8,605 | $30,172 | -$3,701 |
| Inv. Purchases | -$1,645 | -$4,772 | -$6,247 | -$25,905 |
| Inv. Sales/Matur. | $108,491 | $34,499 | $10,068 | $19,472 |
| Other Inv. Act. | -$52 | $10,434 | $31,168 | $5,350 |
| Investing Cash Flow | $99,754 | $33,036 | $52,419 | -$18,278 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$112,485 | $84,000 | $65,499 | -$4,931 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | -$3 | -$2,792 | -$11,125 | -$11,126 |
| Other Fin. Act. | $3,652 | -$3,357 | -$201,191 | -$5,369 |
| Financing Cash Flow | -$108,836 | $77,851 | -$146,817 | -$21,426 |
| Forex Effect | -$177 | $15,440 | $24,090 | $17,751 |
| Net Chg. in Cash | -$5,931 | -$114,431 | -$59,506 | $9,286 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $29,047 | $143,478 | $202,984 | $193,698 |
| End Cash | $23,116 | $29,047 | $143,478 | $202,984 |
| Free Cash Flow | $3,470 | -$257,623 | -$805 | $17,745 |